SCHEMBL7723491

SCHEMBL7723491

CC1(C)CCC(C)(C)c2cc(S(=O)(=O)c3ccc(C(=O)O)cc3)ccc21

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RXRA P19793 15/20 0.69
RXRB P28702 11/20 0.69
RXRG P48443 7/20 0.69
CYP26B1 Q9NR63 1/20 0.66
RARB P10826 9/20 0.64
RARG P13631 8/20 0.64
RARA P10276 5/20 0.63
CYP26A1 O43174 2/20 0.59
CYP3A4 P08684 2/20 0.59
CRABP2 P29373 1/20 0.59
MEN1 O00255 1/20 0.57
ALDH1A1 P00352 1/20 0.57
CYP1A2 P05177 1/20 0.57
CYP2C9 P11712 1/20 0.57
TSHR P16473 1/20 0.57
MAPK1 P28482 1/20 0.57
CYP2C19 P33261 1/20 0.57
KMT2A Q03164 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5680234 0.89 RARB (0.69) RXRARXRBRXRGCYP26B1RARB
SCHEMBL8676373 0.82 RXRA (0.64) RXRARXRBRXRGCYP26B1RARB
SCHEMBL8894039 0.82 RXRA (1.00) RXRARXRBRXRGCYP26B1RARB
SCHEMBL16516911 0.82 CYP26B1 (0.77) RXRARXRBRXRGCYP26B1RARB
SCHEMBL8013234 0.81 CYP26B1 (0.58) RXRARXRBRXRGCYP26B1RARB
SCHEMBL29827631 0.81 RARB (0.81) RXRARXRBRXRGCYP26B1RARB
SCHEMBL846110 0.81 RARB (0.81) RXRARXRBRXRGCYP26B1RARB
SCHEMBL6880686 0.80 RARB (0.68) RXRARXRBRXRGCYP26B1RARB
SCHEMBL15555800 0.80 RXRA (0.61) RXRARXRBRXRGCYP26B1RARB
SCHEMBL17911576 0.80 CYP26B1 (1.00) RXRARXRBRXRGCYP26B1RARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6391287-B1 STORAGE STABLE COMPOSITIONS L'OREAL (FR) 2002-05-21 US claimed
US-5766610-A USEFUL FOR TREATMENT OF MAMMALIAN SKIN AND HAIR, RHEUMATISM, RESIPIRATORY SYSTEM DISORDER, CARDIOVASCULAR AND VISION DISORDERS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1998-06-16 US claimed
EP-0679630-B1 Bicyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses CIRD GALDERMA (FR) 1998-05-06 EP claimed
WO-1997016422-A1 SULFIDES, SULFOXIDES AND SULFONES DISUBSTITUTED WITH A TETRAHYDRONAPHTHALENYL, CHROMANYL, THIOCHROMANYL OR TETRAHYDROQUINOLINYL AND SUBSTITUTED PHENYL OR HETEROARYL GROUP, HAVING RETINOID-LIKE BIOLOGICAL ACTIVITY ALLERGAN (US) 1997-05-09 WO claimed
US-6391287-B1 STORAGE STABLE COMPOSITIONS L'OREAL (FR) 2002-05-21 US disclosed
US-6162815-A RXR-agonist polycyclic aromatic compounds, pharmaceutical/cosmetic compositions comprising said compound and uses thereof CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 2000-12-19 US disclosed
US-6156788-A Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 2000-12-05 US disclosed
US-6015569-A PYRIDINE OR PYRROLE DERIVATIVES OF POLYCYCLIC AROMATICS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 2000-01-18 US disclosed
US-5766610-A USEFUL FOR TREATMENT OF MAMMALIAN SKIN AND HAIR, RHEUMATISM, RESIPIRATORY SYSTEM DISORDER, CARDIOVASCULAR AND VISION DISORDERS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1998-06-16 US disclosed
US-5672710-A SPECIFIC AGONISTS FOR THE RXR RETINOID RECEPTOR RATHER THAN THE RAR ONE; SIDE EFFECT REDUCTION; SKIN AND NERVOUS SYTEM DISORDERS; ANTICARCINOGENIC AGENTS; VISION DEFECTS ALLERGAN (US) 1997-09-30 US disclosed
WO-1997016422-A1 SULFIDES, SULFOXIDES AND SULFONES DISUBSTITUTED WITH A TETRAHYDRONAPHTHALENYL, CHROMANYL, THIOCHROMANYL OR TETRAHYDROQUINOLINYL AND SUBSTITUTED PHENYL OR HETEROARYL GROUP, HAVING RETINOID-LIKE BIOLOGICAL ACTIVITY ALLERGAN (US) 1997-05-09 WO disclosed